Results from study with Episealer® Knee implant accepted for presentation at Australian and New Zealand orthopaedic congress
Episurf Medical (Nasdaq: EPIS B) today announces that the abstract “Episealer, a mini metal implant for chondral injuries in the knee. A prospective single surgeon case series”, has been accepted for a podium presentation at the combined Australian and New Zealand Knee Societies meeting, which will take place in Queenstown, New Zealand, on October 27 - 29, 2022. The presentation will be held by Prof. Karl Eriksson from Stockholm South Hospital and The Karolinska Institute, Stockholm, Sweden. The abstract reports on the clinical outcome for patients having undergone treatment with Episurf